AI Verdict
REGN has stronger fundamentals based on our AI analysis.
HCA vs REGN Fundamental Comparison
| Metric | HCA | REGN |
|---|---|---|
| Revenue | $75.6B | $14.3B |
| Net Income | $6.8B | $4.5B |
| Net Margin | 9.0% | 31.4% |
| ROE | N/A | 14.4% |
| ROA | 11.2% | 11.1% |
| Current Ratio | 0.97x | 4.13x |
| Debt/Equity | N/A | 0.06x |
| EPS | $28.33 | $41.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HCA vs REGN: Frequently Asked Questions
Is HCA or REGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. HCA is rated BUY (75% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.
How does HCA compare to REGN fundamentally?
HCA Healthcare, Inc. has ROE of N/A vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 9.0% vs 31.4% respectively.
Which stock pays higher dividends, HCA or REGN?
HCA has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HCA or REGN for long term?
For long-term investing, consider that HCA has BUY rating with 75% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HCA vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HCA vs REGN, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.